BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 71 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,000 | -76.2% | 8,172 | -66.8% | 0.00% | -66.7% |
| Q2 2019 | $42,000 | +740.0% | 24,630 | +1497.3% | 0.00% | – |
| Q1 2019 | $5,000 | -28.6% | 1,542 | -35.3% | 0.00% | -100.0% |
| Q4 2018 | $7,000 | -61.1% | 2,382 | -17.1% | 0.00% | 0.0% |
| Q3 2018 | $18,000 | +20.0% | 2,874 | +42.6% | 0.00% | 0.0% |
| Q2 2018 | $15,000 | -80.5% | 2,015 | -82.9% | 0.00% | -85.7% |
| Q1 2018 | $77,000 | +26.2% | 11,755 | +121.6% | 0.01% | +40.0% |
| Q3 2017 | $61,000 | +6000.0% | 5,304 | +5204.0% | 0.01% | – |
| Q1 2017 | $1,000 | -98.6% | 100 | -98.1% | 0.00% | -100.0% |
| Q4 2016 | $73,000 | +3550.0% | 5,402 | +4810.9% | 0.01% | – |
| Q3 2016 | $2,000 | -87.5% | 110 | -93.7% | 0.00% | -100.0% |
| Q1 2016 | $16,000 | -69.2% | 1,743 | -31.2% | 0.00% | -75.0% |
| Q4 2015 | $52,000 | +1633.3% | 2,534 | +1001.7% | 0.01% | – |
| Q3 2015 | $3,000 | -50.0% | 230 | -23.3% | 0.00% | -100.0% |
| Q2 2015 | $6,000 | -87.8% | 300 | -85.8% | 0.00% | -83.3% |
| Q1 2015 | $49,000 | – | 2,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
| Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
| Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
| MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
| QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
| KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
| Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
| Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
| First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |